Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

Dosing schedules for pneumococcal conjugate vaccine: considerations for policy makers.

Whitney CG, Goldblatt D, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S172-81. doi: 10.1097/INF.0000000000000076. Review.

PMID:
24336059
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children.

Conklin L, Loo JD, Kirk J, Fleming-Dutra KE, Deloria Knoll M, Park DE, Goldblatt D, O'Brien KL, Whitney CG.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S109-18. doi: 10.1097/INF.0000000000000078. Review.

PMID:
24336053
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Th17 cell based vaccines in mucosal immunity.

Kumar P, Chen K, Kolls JK.

Curr Opin Immunol. 2013 Jun;25(3):373-80. doi: 10.1016/j.coi.2013.03.011. Epub 2013 May 10. Review.

PMID:
23669353
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Blood stream infection is associated with altered heptavalent pneumococcal conjugate vaccine immune responses in very low birth weight infants.

Wynn JL, Li L, Cotten CM, Phelps DL, Shankaran S, Goldberg RN, Carlo WA, Van Meurs K, Das A, Vohr BR, Higgins RD, Stoll BJ, D'Angio CT.

J Perinatol. 2013 Aug;33(8):613-8. doi: 10.1038/jp.2013.5. Epub 2013 Jan 31.

PMID:
23370608
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark.

Harboe ZB, Valentiner-Branth P, Ingels H, Rasmussen JN, Andersen PH, Bjerre CC, Goldblatt D, Ashton L, Haston M, Konradsen HB, Lambertsen L; Danish Pneumococcal Surveillance Collaborating Group.

PLoS One. 2013;8(1):e51460. doi: 10.1371/journal.pone.0051460. Epub 2013 Jan 24.

PMID:
23365635
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.

Ladhani SN, Slack MP, Andrews NJ, Waight PA, Borrow R, Miller E.

Emerg Infect Dis. 2013 Jan;19(1):61-8. doi: 10.3201/eid1901.120741.

PMID:
23259937
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease.

Oishi T, Ishiwada N, Matsubara K, Nishi J, Chang B, Tamura K, Akeda Y, Ihara T, Nahm MH, Oishi K; Japanese IPD Study Group.

Vaccine. 2013 Jan 21;31(5):845-9. doi: 10.1016/j.vaccine.2012.11.010. Epub 2012 Nov 12.

PMID:
23153440
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.

Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL.

Pediatr Infect Dis J. 2012 Mar;31(3):228-34. doi: 10.1097/INF.0b013e31823dcc72.

PMID:
22330164
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.

Jacobs MR, Good CE, Windau AR, Bajaksouzian S, Biek D, Critchley IA, Sader HS, Jones RN.

Antimicrob Agents Chemother. 2010 Jun;54(6):2716-9. doi: 10.1128/AAC.01797-09. Epub 2010 Mar 22.

PMID:
20308374
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk